期刊论文详细信息
| BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 卷:21 |
| Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists | |
| Article | |
| Lamb, Jeffrey P.1,3  Engers, Darren W.1,3,4  Niswender, Colleen M.1,3,4  Rodriguez, Alice L.1,3,4  Venable, Daryl F.1,3  Conn, P. Jeffrey1,3,4  Lindsley, Craig W.1,2,3,4  | |
| [1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA | |
| [2] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA | |
| [3] Vanderbilt Program Drug Discovery, Nashville, TN 37232 USA | |
| [4] Vanderbilt Specialized Chem Ctr MLPCN, Nashville, TN 37232 USA | |
| 关键词: mGlu5; NAM; PAM; Allosteric; Metabotropic; Glutamate; | |
| DOI : 10.1016/j.bmcl.2010.11.119 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
This Letter describes a chemical lead optimization campaign directed at a weak mGlu(5) NAM discovered while developing SAR for the mGlu(5) PAM, ADX-47273. An iterative parallel synthesis effort discovered multiple, subtle molecular switches that afford potent mGlu(5) NAMs, mGlu(5) PAMs as well as mGlu(5) partial antagonists. (C) 2010 Elsevier Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_bmcl_2010_11_119.pdf | 1064KB |
PDF